Northland Capmk Estimates Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Stock analysts at Northland Capmk issued their FY2026 earnings per share (EPS) estimates for shares of Astera Labs in a report released on Thursday, January 2nd. Northland Capmk analyst G. Richard expects that the company will post earnings per share of $0.71 for the year. Northland Capmk currently has a “Hold” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The company had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $97.50 million. The firm’s revenue for the quarter was up 47.1% on a year-over-year basis.

A number of other research analysts have also recently issued reports on ALAB. JPMorgan Chase & Co. raised their price target on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Citigroup started coverage on Astera Labs in a research note on Monday, November 18th. They issued a “buy” rating and a $120.00 target price for the company. Barclays boosted their price target on Astera Labs from $70.00 to $87.00 and gave the company an “overweight” rating in a research note on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price objective on Astera Labs from $60.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, November 5th. Finally, Roth Mkm upped their target price on Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and a consensus price target of $105.75.

Astera Labs Stock Up 1.9 %

Shares of Astera Labs stock opened at $143.64 on Monday. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39. The company has a 50 day moving average price of $111.04 and a 200 day moving average price of $72.22.

Insiders Place Their Bets

In other Astera Labs news, General Counsel Philip Mazzara sold 25,000 shares of Astera Labs stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $60.74, for a total value of $1,518,500.00. Following the completion of the transaction, the general counsel now owns 300,564 shares of the company’s stock, valued at approximately $18,256,257.36. The trade was a 7.68 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Sanjay Gajendra sold 740,000 shares of the company’s stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $96.59, for a total value of $71,476,600.00. Following the completion of the transaction, the insider now directly owns 775,000 shares of the company’s stock, valued at $74,857,250. The trade was a 48.84 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 1,978,119 shares of company stock worth $186,618,509.

Institutional Trading of Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Hollencrest Capital Management purchased a new position in shares of Astera Labs during the 3rd quarter valued at approximately $26,000. US Bancorp DE purchased a new position in Astera Labs in the 3rd quarter valued at about $46,000. First Horizon Advisors Inc. acquired a new stake in shares of Astera Labs in the third quarter worth approximately $49,000. Allworth Financial LP increased its position in shares of Astera Labs by 445.5% during the third quarter. Allworth Financial LP now owns 1,091 shares of the company’s stock worth $57,000 after purchasing an additional 891 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Astera Labs by 78.3% in the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after purchasing an additional 224 shares during the last quarter. 60.47% of the stock is owned by institutional investors and hedge funds.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.